Join
Live feed
·
PRReleasevia Quantisnow
Alpine Immune Sciences Inc. logo

Alpine Immune Sciences Presents Initial Clinical Data on Povetacicept in Autoimmune Glomerulonephritis in a Late-Breaking Poster Session at the American Society of Nephrology Kidney Week 2023

ByQuantisnow·Wall Street's wire, on your screen.
ALPN· Alpine Immune Sciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALPN (Alpine Immune Sciences Inc.) and more on Quantisnow.